SHAM INNOVATION SANTé
Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth and development phases of their life cycle.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-12 | Therapixel | Sham Innovation Santé investment in Series B - Therapixel | 15 M EUR |
2022-05-10 | Germitec SAS | Sham Innovation Santé investment in Venture Round - Germitec SAS | 11 M EUR |
2022-03-31 | Cairdac | Sham Innovation Santé investment in Series A - Cairdac | 17 M EUR |
2021-09-16 | Amolyt Pharma | Sham Innovation Santé investment in Series B - Amolyt Pharma | 80 M USD |
2021-08-02 | Keenturtle | Sham Innovation Santé investment in Venture Round - Keenturtle | 1.5 M EUR |
2021-07-21 | Coave Therapeutics | Sham Innovation Santé investment in Series B - Coave Therapeutics | 33 M EUR |
2021-04-27 | Mablink Bioscience | Sham Innovation Santé investment in Seed Round - Mablink Bioscience | 4 M EUR |
2020-11-04 | AbolerIS Pharma | Sham Innovation Santé investment in Seed Round - AbolerIS Pharma | 2.5 M EUR |
2019-07-31 | Amolyt Pharma | Sham Innovation Santé investment in Series A - Amolyt Pharma | 67 M EUR |
2018-12-12 | CarThera | Sham Innovation Santé investment in Series B - CarThera | 9 M EUR |